Trials / Completed
CompletedNCT02174042
The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis
The Effect of Tang Ning Tongluo Formula, a Traditional Chinese Miao Medicine, in Type 2 Diabetics: A Retrospective Clinical Analysis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Guizhou Bailing Group Pharmaceutical Co Ltd · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this retrospective study is to review and describe safety and efficacy of Tang Ning Tong Luo capsule.
Detailed description
The aim of this retrospective study is to review and describe safety and efficacy of Tang Ning Tong Luo capsule,a traditional Chinese Miao medicine, in Type 2 Diabetics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tangning Tongluo Capsule | Taken drugs 3 times a day, with each time 3 grains |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-08-01
- Completion
- 2014-09-01
- First posted
- 2014-06-25
- Last updated
- 2014-09-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02174042. Inclusion in this directory is not an endorsement.